Insider transaction details
Astera Labs, Inc. reported that Chief Executive Officer Mohan Jitendra sold 157,501 shares of common stock on March 17, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The sales were executed under a pre-arranged 10b5-1 trading plan and produced total proceeds of $20,723,773.
Tranche breakdown
- 8,754 shares at a weighted average price of $125.5575
- 5,746 shares at $126.6444
- 3,624 shares at $127.4731
- 7,907 shares at $128.6415
- 11,120 shares at $129.6162
- 13,880 shares at $130.7410
- 22,766 shares at $131.6101
- 43,289 shares at $132.7214
- 22,309 shares at $133.6642
- 18,105 shares at $134.6738
Post-transaction ownership
Following these dispositions, Mohan Jitendra continues to indirectly own 4,531,732 shares of Astera Labs common stock through a living trust. The filing also notes additional direct and indirect ownership through several other trusts.
Share performance and valuation context
The insider sale comes against a backdrop of recent share-price swings. Astera Labs shares have returned 83% over the past 12 months, yet the stock has declined 48.6% over the most recent six-month period from its 52-week high of $262.90. An investing analysis cited in the filing indicates the stock appears overvalued at current levels and lists the company among those on the most overvalued roster. The company trades at a price-to-earnings ratio of 103, while its price/earnings-to-growth ratio stands at 0.33, which the analysis describes as suggesting a more reasonable valuation relative to growth expectations.
Recent operating results
Astera Labs reported strong fourth-quarter 2025 results. The company posted earnings per share of $0.58, exceeding the projected $0.51 estimate by 13.73%. Revenue for the quarter reached $270.6 million, representing a 92% increase year over year. Those outcomes are characterized in the filing as indicative of the company’s recent positive performance. The filing notes analysts have taken notice of the results, while also stating that specific upgrades or downgrades by firms were not mentioned in the available information.
What is clear and what remains uncertain
The public disclosures establish the scale and mechanics of the insider sale and document the CEO’s remaining ownership through trusts. They also confirm strong quarterly operating results and mixed near-term stock performance. The filing does not, however, offer commentary on motives behind the transactions beyond their execution under a 10b5-1 plan, nor does it provide detail on any analyst rating changes following the quarterly report.